The role of Amicar in decreasing perioperative blood loss in idiopathic scoliosis

Spine

Volumn 30, Issue 17 SUPPL., 2005, Pages

  Thompson, George H ^a   Florentino Pineda, Ivan ^a   Poe Kochert, Connie ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Adolescent idiopathic scoliosis; Amicar (epsilon aminocaproic acid); Perioperative blood loss fibrinogen; Posterior spinal fusion; Same day anterior and posterior spinal fusion; Segmental spinal instrumentation

Indexed keywords

AMINOCAPROIC ACID; FIBRINOGEN;

ANESTHESIA INDUCTION; ANTERIOR SPINE FUSION; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; HEALTH CARE COST; HUMAN; IDIOPATHIC SCOLIOSIS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL; SPINE FUSION; TUBE; WOUND CLOSURE;

EID: 24744458362     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/01.brs.0000175188.05542.a9     Document Type: Article

References (35)

1. Guay J, Haig M, Lortie L, et al. Predicting blood loss in surgery for idiopathic scoliosis. Can J Anaesth 1994;41:775-81.
2. McNeill TW, DeWald RL, Kuo KN, et al. Controlled hypotensive anesthesia in scoliosis surgery. J Bone Joint Surg Am 1974;56:1167-72.
3. Patel NJ, Patel BS, Paskin S, et al. Induced moderate hypotensive anesthesia or spinal fusion and Harrington rod instrumentation. J Bone Joint Surg Am 1985;67:1384-7.
4. Phillips WA, Hensinger RN. Control of blood loss during scoliosis surgery. Clin Orthop 1988;229:88-92.
5. Relton JES, Hall JE. An operation frame for spinal fusion: a new apparatus designed to reduce haemorrhage during operation. J Bone Joint Surg Br 1967;49:327.
6. Cowell MR, Swickard JW. Autotransfusion in children's orthopaedics. J Bone Joint Surg Br 1974;56:908.
7. Florentino-Pineda I, Blakemore LC, Thompson GH, et al. The effect of epsilon aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion: a preliminary prospective study. Spine 2001;26:1147-51.
8. Florentino-Pineda I, Thompson GH, Poe-Kochert C, et al. The effect of Amicar on perioperative blood loss in idiopathic scoliosis: the results of a prospective, randomized double-blind study. Spine 2004;29:233-8.
9. Urban MK, Beckman J, Gordon M, et al. The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. Spine 2001;26:1152-5.
10. Cole JW, Murrary DJ, Snider RJ, et al. Aprotinin reduces blood loss during spinal surgery in children. Spine 2003;28:2482-5.
11. Koshhal K, Clark P, Jarvis J, et al. The efficacy of aprotinin in reducing blood loss in spinal fusion for idiopathic scoliosis. Presented at Pediatric Orthopaedic Society of North America Annual Meeting, Cancun, Mexico, May 1-5, 2001.
12. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999;57:1005-32.
13. Rao BH, Saxena N, Chauhan S, et al. Epsilon aminocaproic acid in paediatric cardiac surgery to reduce postoperative blood loss. Indian J Med Res 2000;111:57-61.
14. Vander Salm TJ, Kaur S, Lancey RA, et al. Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. J Thorac Cardiovasc Surg 1996;112:1098-107.
15. Williams GD, Bratton SL, Riley EC, et al. Efficacy of epsilon-aminocaproic acid in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 1999;13:304-8.
16. Chauhan S, Das SN, Bisoi A, et al. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 2004;18:141-3.
17. Bjure J, Grimby G, Nachemson A. Correction of body height in predicting spirometric values in scoliotic patients. Scand J Clin Lab Invest 1968;21:190-2.
18. Harley BJ, Beaupre LD, Jones A, et al. The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study. Can J Surg 2002;45:185-90.
19. Lentchener C, Cottin P, Bouaziz H, et al. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Anesth Analg 1999;89:590-7.
20. Murkin JM, Shannon NA, Bourne RB, et al. Aprotinin decreases blood loss in patients undergoing revision in bilateral total hip arthroplasty. Anesth Analg 1995;80:343-8.
21. Alanay A, Acaroglu E, Özdemir O, et al. Effects of deamino-8-d-arginin vasopressin on blood loss and coagulation factors in scoliosis surgery, a double-blind randomized clinical trial. Spine 1999;24:877-82.
22. Brenn BR, Theroux MC, Dabney KW, et al. Clotting parameters and thromboelastography in children with neuromuscular and idiopathic scoliosis undergoing posterior spinal fusion. Spine 2004;29:E310-4.
23. Krohn CD, Reikeras O, Bjornsen S, et al. Fibrinogen, fibrin and its degradation products in drained blood after major orthopaedic surgery. Blood Coagul Fibrinolysis 1999;10:167-71.
24. Tuman KJ, Spiess RD, McCarthy RJ, et al. Effects of progressive blood loss on coagulation as measured by thromboelastography. Anesth Analg 1987;66:856-63.
25. Wei KL, Lin CJ, Lai KA. Changes in coagulation profile after orthopedic surgery. J Formos Med Assoc 1995;94:541-7.
26. Greilich DE, Brouse CF, Rinder CS, et al. Effects of epsilon-aminocaproic acid and aprotinin in leukocyte-platelet adhesion in patients undergoing cardiac surgery. Anesthesiology 2004;100:225-33.
27. Tobias JD. Strategies for minimizing blood loss in orthopedic surgery. Semin Hematol 2004;41(suppl):145-56.
28. Booth D, Kothmann E, Tidmarsh M. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. J Bone Joint Surg Br 2003;85:174-7.
29. Amar D, Grant FM, Zhang H, et al. Antifibrinolytic therapy and perioperative blood loss in cancer patients undergoing major orthopedic surgery. Anesthesiology 2003;98:337-42.
30. Samama CM, Langeron O, Rosencher N, et al. Aprotinin versus placebo in major orthopedic surgery: a randomized, double-blinded, dose-ranging study. Anesth Analg 2002;95:287-95.
31. Samama CM. A direct antifibrinolytic agent in major orthopaedic surgery. Orthopedics 2004;27(suppl 6):3675-80.
32. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood loss as the outcome. Anesth Analg 1997;85:1258-67.
33. Munoz JJ, Birkmeyer NJ, Birkmeyer JD, et al. Is epsilon-aminocaproic acid as effective as Aprotinin in reducing bleeding with cardiac surgery? A meta-analysis. Circulation 1999;99:81-9.
34. Slaughter TF, Green berg CS. Antifibrinolytic drugs and perioperative hemostasis. Am J Hematol 1997;56:32-6.
35. Ray MJ, O'Brien MF. Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety, and cost. Ann Thorac Surg 2001;71:838-43.